5-Amino-1MQ
Also known as: 5-Amino-1MQ
A pill that aims to switch fat cells from 'storage mode' to 'burning mode' by blocking an enzyme (NNMT) that is overactive in the fat tissue of overweight people. Not technically a peptide, but commonly sold alongside them. Unlike appetite suppressants, this targets the fat cells directly rather than making you eat less. The science is promising in lab studies, but there are no completed human trials yet.
Dosage
50-100 mg oral once or twice daily
Dosages shown are for research reference only. Always consult a qualified healthcare provider.
Administration
Oral (capsule)

Shop Research-Grade Peptides
99%+ purity · US-based · third-party lab tested
Getting Started — Here's What You'll Need
Effects
Fat Metabolism
Shifts adipocytes from fat storage to fat burning by preserving NAD+ and SAM pools.
Metabolic Enhancement
NNMT inhibition activates sirtuin enzymes and mitochondrial biogenesis.
Insulin Sensitivity
Preclinical improvements in glucose handling and cholesterol.
Mechanism of Action
5-Amino-1MQ is a selective inhibitor of nicotinamide N-methyltransferase (NNMT), a cytoplasmic enzyme that is significantly overexpressed in white adipose tissue of obese individuals. NNMT catalyzes the methylation of nicotinamide (a form of vitamin B3) using S-adenosyl methionine (SAM) as the methyl donor, producing 1-methylnicotinamide and S-adenosyl homocysteine. This reaction effectively depletes two critical metabolic cofactors — NAD+ precursors and SAM — from fat cells.
By inhibiting NNMT, 5-Amino-1MQ preserves the cellular pools of both nicotinamide (which feeds NAD+ biosynthesis via the salvage pathway) and SAM (the universal methyl donor required for hundreds of methylation reactions). Increased NAD+ availability activates sirtuin enzymes (particularly SIRT1 and SIRT3), which are master regulators of cellular metabolism — they deacetylate and activate PGC-1alpha (promoting mitochondrial biogenesis), enhance fatty acid oxidation, and suppress lipogenic gene expression. The net effect is that adipocytes shift from a fat-storing to a fat-burning metabolic state.
In preclinical models, NNMT inhibition reduced adipocyte size, decreased total body fat mass, and increased energy expenditure without affecting food intake — suggesting the weight loss mechanism is primarily metabolic rather than appetite-driven. Additionally, NNMT inhibition has shown improvements in insulin sensitivity and reductions in plasma cholesterol. However, all published efficacy data comes from cell culture and rodent studies; no human clinical trials have been completed, so the translational relevance remains uncertain.
Regulatory Status
Not FDA approved. Preclinical research compound. Available through research chemical suppliers and some compounding pharmacies.
Risks & Safety
Common
stomach discomfort, nausea.
Serious
no completed human clinical trials, blocking NNMT could affect important cellular processes that are not yet fully understood.
Compare 5-Amino-1MQ With
Research Papers
60Published: February 7, 2026
AI Summary
Researchers developed a peptide-based fluorescent probe that detects heparin with exceptional sensitivity in under 30 seconds, even in living cells and zebrafish. The probe works by forming nanoaggregates with heparin and could enable portable, point-of-care testing for patients on anticoagulant therapy.
Published: February 12, 2026
AI Summary
A deep learning model was built and validated to predict short-term death risk in heart failure patients using ECG data. With heart failure mortality rising again after years of decline, such tools could help clinicians identify high-risk patients who need more intensive care.
Published: February 11, 2026
AI Summary
A new copper-catalyzed method enables the creation of chiral nitrogen-containing compounds from amino carbonyls in a way that works with peptides. The approach uses an unconventional reaction pathway that could expand options for synthesizing drug-like molecules.
Published: February 11, 2026
AI Summary
Scientists identified a new type of sugar-derived cross-link called MIDAL that forms between arginine residues and can become the dominant age-related modification in certain proteins. Understanding these cross-links matters because they are linked to many age-related diseases and may be reversible.
Published: February 5, 2026
AI Summary
Artemisia scoparia essential oil is known to have antioxidant and anti-inflammatory properties, but how it works remains poorly understood. The abstract frames the need for further research into its mechanisms.
Published: February 11, 2026
AI Summary
The protein Etv3 was identified as a key regulator that keeps dendritic cells in a tolerance-promoting state. When Etv3 was removed in mice, autoimmune-like disease worsened, suggesting it may be relevant to human conditions like lupus.
Published: February 11, 2026
AI Summary
Engineering mosquito gut bacteria to produce anti-malarial peptides can block parasite development by up to 98% in some setups. The approach could complement existing malaria control, though safety and field testing remain hurdles before wider use.
Published: February 11, 2026
AI Summary
GLP-1 drugs show promise in lab models of ALS but current clinical data do not support their use and raise safety concerns, especially around weight loss. More ALS-specific trials are needed before considering these drugs for this population.
Published: February 11, 2026
AI Summary
Blocking the VEGF-C-Flt4 pathway reduced brain swelling in rats after stroke by limiting activation of meningeal lymphatic cells. Targeting this pathway could offer a new way to reduce stroke-related inflammation and edema.
Published: February 11, 2026
AI Summary
In rats with kidney injury, Remdesivir worsened damage by reducing mitochondrial biogenesis and increasing cell death, especially when given subcutaneously. The findings support caution when using Remdesivir in patients with impaired kidney function.
Published: February 11, 2026
AI Summary
Weight-loss drugs that mimic GLP-1 mainly reduce appetite but do little to boost energy expenditure. Glucagon receptor agonists may help by increasing fat burning and metabolic rate, potentially improving long-term weight loss when combined with GLP-1 drugs.
Published: February 11, 2026
AI Summary
Combining Fu brick tea extract with millet reduced obesity in mice by improving digestion, shifting gut bacteria, and increasing satiety signals. The combination could inform development of starch-based foods that support metabolic health.
Published: February 11, 2026
AI Summary
A rice-derived peptide called PHP1 was identified, produced in bacteria, and shown to reduce inflammation in cells and mice by blocking NF-κB. The work supports scalable production of anti-inflammatory peptides for functional foods.
Published: February 11, 2026
AI Summary
A one-step method was developed to attach four drug molecules to antibodies with high uniformity. The resulting antibody-drug conjugates showed strong tumor suppression and good stability, advancing options for cancer treatment.
Published: February 11, 2026
AI Summary
Combining a CD4-mimic molecule with a neutralizing antibody into a single conjugate improved anti-HIV activity compared to using both separately. The approach could inform new HIV treatment strategies, though antibody-dependent immune cell killing was reduced.
Published: February 11, 2026
AI Summary
GLP-1 drugs like semaglutide are widely used for diabetes and weight loss, but emerging reports suggest a possible link to a rare form of vision loss. The abstract highlights the need to weigh this potential risk.
Published: December 11, 2026
AI Summary
The allergy drug loratadine restored the effectiveness of colistin against resistant bacteria by blocking a key resistance mechanism. Repurposing existing drugs alongside antibiotics could help combat drug-resistant infections.
Published: February 11, 2026
AI Summary
The Sim-Q questionnaire was developed to measure how simple or complex diabetes treatment feels to patients. The study evaluated whether the questionnaire is reliable and valid for use in type 2 diabetes.
Published: February 11, 2026
AI Summary
Long-term follow-up of Japanese patients receiving peptide receptor radionuclide therapy for neuroendocrine tumors was analyzed for survival and safety. The work addresses gaps in knowledge about durable outcomes of this treatment.
Published: February 11, 2026
AI Summary
A mathematical model showed that how quickly the body clears infliximab strongly affects treatment success in inflammatory bowel disease. The model could support personalized dosing and drug monitoring to improve outcomes.
Published: February 11, 2026
AI Summary
Obesity caused by hypothalamic damage is hard to treat with diet and exercise alone, but newer drugs targeting appetite and metabolism show promise. Combination therapies may eventually reduce the need for bariatric surgery in this population.
Published: February 11, 2026
AI Summary
NOD2 is an immune sensor whose gene variants are linked to several diseases. The review summarizes what is known about these conditions and the biological roles of NOD2.
Published: February 11, 2026
AI Summary
Kuwaiti experts recommend earlier screening, better coordination across specialties, and broader use of GLP-1 drugs to address the overlapping burdens of obesity, diabetes, heart disease, and kidney disease. Semaglutide was highlighted as a valuable option.
Published: February 11, 2026
AI Summary
A small RNA called miR-7052 helps protect the blood-brain barrier during sepsis by suppressing two proteins that promote leakage. Restoring or mimicking miR-7052 could be a strategy to limit brain damage in severe infection.
Published: February 11, 2026
AI Summary
A fusion vaccine combining antigens from latent and active tuberculosis triggered stronger immune responses than single antigens in infected people and mice. Both protein and DNA versions of the vaccine showed robust immunogenicity.
Published: February 11, 2026
AI Summary
Genes that spread colistin resistance among bacteria have evolved into multiple variants and pose a growing threat. The review covers how these genes work, how they spread, and potential countermeasures including surveillance and new inhibitors.
Published: February 11, 2026
AI Summary
Four shellfish species were digested in the lab to compare their peptide profiles and potential bioactive effects. The abstract describes the study design without reporting conclusions.
Published: February 11, 2026
AI Summary
A bacterial peptide called microcin H47 killed triple-negative breast cancer cells while sparing normal cells, largely through apoptosis. The findings support further development of this peptide as a potential cancer treatment.
Published: February 10, 2026
AI Summary
A vaccine targeting 209 frameshift peptides produced strong, broad, and durable immune responses in people with Lynch syndrome. The approach could help prevent the multiple cancer types these individuals are at higher risk of developing.
Published: February 5, 2026
AI Summary
During fasting, muscle proteins undergo widespread modification by a ketone-derived tag that may help regulate metabolism. The work reveals how muscle adapts to starvation at the molecular level.
Published: February 11, 2026
AI Summary
The study examined how long-acting insulin analogs affect the ability to measure natural insulin and C-peptide production in the body. Understanding this matters for distinguishing type 1 from type 2 diabetes when patients are already on insulin.
Published: February 11, 2026
AI Summary
Merkel cells in the vagina may have mechanosensory roles similar to those in skin, but their function there is still unclear. The study aimed to characterize these cells and their potential roles.
Published: February 11, 2026
AI Summary
Blocking the NLRP3 inflammasome could offer a new gene therapy approach for Parkinson's, given its role in neuroinflammation. The abstract outlines this rationale without detailing study outcomes.
Published: February 11, 2026
AI Summary
A new model was developed to predict serious heart complications after surgery for bile duct cancer using preoperative cardiac ultrasound. The tool could help identify high-risk patients before surgery.
Published: February 12, 2026
AI Summary
Innate lymphoid cells can either worsen or dampen multiple sclerosis depending on subtype and context. Understanding and targeting these cells may lead to more precise treatments for MS.
Published: February 11, 2026
AI Summary
A cytomegalovirus protein activates itself using a built-in peptide, which helps the virus hijack host cell signaling. Understanding this mechanism could inform new antiviral strategies.
Published: February 11, 2026
AI Summary
A peptide that disrupts a three-protein complex in kidney cancer cells slowed tumor growth and spread in lab models. The findings point to a potential new target for kidney cancer therapy.
Published: February 11, 2026
AI Summary
Abstract too short to summarize.
Published: February 11, 2026
AI Summary
Abstract too short to summarize.
Published: February 11, 2026
AI Summary
Only a small subset of VIP neurons in the brain's clock region responds to vasopressin, and this response helps maintain robust daily rhythms. The work maps how different neuron types communicate within the circadian clock.
Published: February 11, 2026
AI Summary
Gene expression in immune cells was mapped in response to different stimuli and genetic perturbations. The dataset helps clarify which transcription factors drive inflammatory responses and how drugs might alter them.
Published: February 11, 2026
AI Summary
FDA and industry experts met to discuss how to assess immunogenicity risk for generic peptides and oligonucleotides. The workshop aimed to improve regulatory frameworks for these complex products.
Published: February 12, 2026
AI Summary
Most secreted and membrane proteins in human cells depend on the signal recognition particle for proper delivery. The work also identified compensatory pathways and quality control mechanisms when this system is impaired.
Published: February 11, 2026
AI Summary
A protein called SerpinB2 helps fat tissue macrophages survive by supporting mitochondrial function. Obesity reduces SerpinB2, contributing to metabolic dysfunction, but restoring it or giving a glutathione precursor improved metabolic health in mice.
Published: February 11, 2026
AI Summary
A new method called PRICE detects tiny differences in miRNA sequences with high sensitivity, which could improve cancer diagnosis and prognosis. The approach uses peptide nucleic acid blockers with CRISPR to distinguish closely related miRNAs.
Published: February 11, 2026
AI Summary
Staphylococcus aureus uses a distinct mechanism to start protein synthesis that differs from other bacteria. A small leader peptide was also found to control biofilm formation by linking nutrient availability to gene expression.
Published: February 11, 2026
AI Summary
Loss of estrogen after menopause turns on a sialylation pathway in bone-eating cells that accelerates bone loss. Blocking this pathway with a sialidase reduced bone loss in mice, suggesting a potential therapeutic target for osteoporosis.
Published: February 12, 2026
AI Summary
An aptamer that binds a conserved coronavirus protein blocked inflammation across multiple coronaviruses. A combined aptamer-antisense construct reduced viral load and lung inflammation in mice, offering a template for future pandemic preparedness.
Published: February 11, 2026
AI Summary
Chiral gold nanoparticles guided by peptides catalyzed the formation of mirror-image polymers with different cancer-killing effects. The approach could support development of chirality-selective cancer therapies.
Published: February 12, 2026
AI Summary
A case of a child with familial hypercholesterolemia despite statin therapy prompts a discussion of current options for early diagnosis and treatment. The abstract frames questions about safety and effectiveness in pediatric patients.
Published: February 12, 2026
AI Summary
Newer cortisol assays may require a lower cutoff than the traditional 18 μg/dL for diagnosing adrenal insufficiency. The study evaluated whether a revised threshold of 15.6 μg/dL improves diagnostic accuracy.
Published: February 12, 2026
AI Summary
Rolling out flash glucose monitoring for adults with type 2 diabetes on intensive insulin poses organizational challenges for health systems. The abstract introduces this topic without reporting outcomes.
Published: February 12, 2026
AI Summary
Oncostatin M and leukemia inhibitory factor are linked to muscle loss in malnutrition. The study aimed to determine their role in sarcopenia in cancer patients with malnutrition.
Published: April 14, 2026
AI Summary
A sugar fragment from a traditional herb boosted immune function and repaired gut barrier damage in immunosuppressed mice. The work supports development of immunomodulatory products from this plant.
Published: April 14, 2026
AI Summary
A sugar from a Chinese medicinal plant extended lifespan and reduced aging-related decline in worms and mice by dampening insulin/IGF-1 signaling. The findings support exploration of this compound for anti-aging applications.
Published: April 14, 2026
AI Summary
Yeast beta-glucan and chicory inulin helped restore normal daily rhythms and reduced brain inflammation in mice with systemic inflammation. The effects were similar to melatonin and ibuprofen, suggesting prebiotics may support circadian and brain health.
Published: February 11, 2026
AI Summary
Two protein modifications that look identical by standard mass spectrometry were distinguished using chromatography and a specialized fragmentation method. The approach was used to confirm lactylation at a specific site in aldolase across cell types.
Published: February 11, 2026
AI Summary
Blocking CXCR4 with an oncolytic virus remodeled blood vessels around ovarian tumors and improved T cell infiltration and anti-tumor activity. The results support combining this approach with adoptive T cell therapy for ovarian cancer.
Published: February 11, 2026
AI Summary
At typical and higher concentrations, tramadol did not significantly affect platelet function in blood samples from healthy volunteers. The findings support the safety of tramadol regarding bleeding risk, though larger studies are needed.
Published: February 9, 2026
AI Summary
Regions of proteins that bind sugars often overlap with regions prone to aggregation, and many disease-linked mutations fall in these sites. The work refines understanding of how protein structure, sugar binding, and aggregation interact.
Frequently Asked Questions
What is 5-Amino-1MQ?
A pill that aims to switch fat cells from 'storage mode' to 'burning mode' by blocking an enzyme (NNMT) that is overactive in the fat tissue of overweight people. Not technically a peptide, but commonly sold alongside them. Unlike appetite suppressants, this targets the fat cells directly rather than making you eat less. The science is promising in lab studies, but there are no completed human trials yet.
What is 5-Amino-1MQ used for?
A pill that aims to switch fat cells from 'storage mode' to 'burning mode' by blocking an enzyme (NNMT) that is overactive in the fat tissue of overweight people. Not technically a peptide, but commonly sold alongside them. Unlike appetite suppressants, this targets the fat cells directly rather than making you eat less. The science is promising in lab studies, but there are no completed human trials yet.
What is the dosage for 5-Amino-1MQ?
Research: 50-100 mg oral once or twice daily. No FDA-approved dosing guidelines. No established cycling protocol.
What are the side effects of 5-Amino-1MQ?
Common: stomach discomfort, nausea. Serious: no completed human clinical trials, blocking NNMT could affect important cellular processes that are not yet fully understood.
How does 5-Amino-1MQ work?
5-Amino-1MQ is a selective inhibitor of nicotinamide N-methyltransferase (NNMT), a cytoplasmic enzyme that is significantly overexpressed in white adipose tissue of obese individuals. NNMT catalyzes the methylation of nicotinamide (a form of vitamin B3) using S-adenosyl methionine (SAM) as the methyl donor, producing 1-methylnicotinamide and S-adenosyl homocysteine. This reaction effectively depletes two critical metabolic cofactors — NAD+ precursors and SAM — from fat cells. By inhibiting NNMT, 5-Amino-1MQ preserves the cellular pools of both nicotinamide (which feeds NAD+ biosynthesis via the salvage pathway) and SAM (the universal methyl donor required for hundreds of methylation reactions). Increased NAD+ availability activates sirtuin enzymes (particularly SIRT1 and SIRT3), which are master regulators of cellular metabolism — they deacetylate and activate PGC-1alpha (promoting mitochondrial biogenesis), enhance fatty acid oxidation, and suppress lipogenic gene expression. The net effect is that adipocytes shift from a fat-storing to a fat-burning metabolic state. In preclinical models, NNMT inhibition reduced adipocyte size, decreased total body fat mass, and increased energy expenditure without affecting food intake — suggesting the weight loss mechanism is primarily metabolic rather than appetite-driven. Additionally, NNMT inhibition has shown improvements in insulin sensitivity and reductions in plasma cholesterol. However, all published efficacy data comes from cell culture and rodent studies; no human clinical trials have been completed, so the translational relevance remains uncertain.
How is 5-Amino-1MQ administered?
5-Amino-1MQ is administered via oral (capsule).
What is the half-life of 5-Amino-1MQ?
The half-life of 5-Amino-1MQ is 12-16 hours (limited pharmacokinetic data).
Is 5-Amino-1MQ legal?
Not FDA approved. Preclinical research compound. Available through research chemical suppliers and some compounding pharmacies.
Related Peptides
Adipotide
An extreme experimental approach to fat loss — it physically destroys the blood vessels that feed fat tissue, starving fat cells until they die. Originally developed using anti-cancer technology at MD Anderson Cancer Center. While it did reduce fat in monkey studies, it also caused serious kidney damage, which has effectively stopped its development. Not available for human use.
AICAR
A natural compound that activates your cells' energy sensor — the same pathway that turns on during exercise. Mimics the metabolic effects of endurance exercise at the cellular level, helping with fat burning, glucose uptake, and building more mitochondria. Banned by WADA as a metabolic modulator after detection in professional cycling.
AOD-9604
A small piece of human growth hormone (amino acids 176-191) designed to keep only the fat-burning effects while removing the unwanted side effects of full growth hormone (like swelling and blood sugar problems). The idea is promising — burn fat without the downsides — but it failed to show significant weight loss in clinical trials. Still widely used in research and wellness clinics despite the weak clinical evidence.
Cagrilintide
A long-acting version of amylin, a natural hormone your body releases after eating that tells your brain you're full. It works through a completely different pathway than GLP-1 drugs like semaglutide, which is why combining them (as CagriSema) produces even better results. On its own, it reduces how much you eat per meal by signalling fullness earlier. Developed by Novo Nordisk, mainly as part of the CagriSema combination.